3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Polyps
2
Hyperplasia
2
Colorectal Neoplasms
2
Weight Loss
1
Psoriasis
1
Osteoarthritis
1
Colitis, Ulcerative
1
Cholangiocarcinoma
1
Carcinoma, Hepatocellular
1
Cancer Cachexia
1
Cachexia
1
Breast Neoplasms
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Anorexia
1
Adenomatous Polyps
1
Adenomatous Polyposis Coli
1
Interventions
Data Collection
3
telitacicept
1
human papillomavirus vaccine, L1 type 16, 18
1
Vitamin D
1
Telemedicine
1
Plasma Exchange
1
Mycophenolic Acid
1
Immune Checkpoint Inhibitors
1
Fish Oils
1
Fatty Acids, Omega-3
1
Eicosapentaenoic Acid
1
Docosahexaenoic Acids
1
Cholecalciferol
1
CT-P13
1
Azathioprine
1
Ashwagandha
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Autoimmune Diseases
×
Eicosapentaenoic Acid
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts